Modern Medicine Cases

ASCRS names Stephen H. Speares executive directorThe American Society of Cataract and Refractive Surgery’s (ASCRS) Executive Committee announced that Stephen H. “Steve” Speares will serve as the society’s next executive director, according to a prepared statement.
3 ways PCPs can foster behavioral health relationships and increase reimbursement
3 ways PCPs can foster behavioral health relationships and increase reimbursementPrimary care physicians (PCP) see patients for a wide variety of reasons, but according to a recent study, there’s one category that stands out above the rest—behavioral health.
Why meibography can be a game-changer in treating dry eye
Why meibography can be a game-changer in treating dry eyeDry eye disease (DED) has been historically underserved. Leslie E. O’Dell, OD, FAAO, summarizes what equipment is available today to help you begin evaluating your dry eye patients’ glands.
Data demonstrate real-world benefits of fluocinolone acetonide implantReal-world data on a fluocinolone acetonide intravitreal implant show sustained benefits of switching to the treatment in pseudophakic eyes that are insufficiently responsive to other therapies.
Quarterly Questions is the new gold standard for board certificationDr. Mali discusses how the Quarterly Questions program assesses fundamental (“walking around”) knowledge needed in the everyday practice of ophthalmology (40 questions annually), as well as the application of information from five journal articles (10 questions annually).
To curb opioid abuse, new technologies must be embraced
To curb opioid abuse, new technologies must be embracedThe opioid epidemic is exacting a lethal toll on the country. We must redouble and accelerate efforts to slow—and hopefully reverse—the current opioid epidemic.
Femtosecond laser-assisted cataract surgery: How far have we come?During the XXXV Congress of the ESCRS, an international panel of expert FLACS users gathered to share their research and insights, and to learn from the experiences of their colleagues.
Cellular therapy of the corneal stroma: Real approach or science fiction?The first human clinical trial to preliminarily evaluate the safety and efficacy of cellular therapy with mesenchymal stem cells for the corneal stroma has shown promise.
Electroretinography: Out of the laboratory and into the clinicOCT has many benefits, yet falls short of reliably diagnosing and managing retinopathies and glaucoma. ERG remains the stalwart method for this application and this article highlights how technological advancements have enabled its introduction to the clinic.
Diagnosing early-stage AMD with a dark adaptation deviceA dark adaptometer (AdaptDx; MacuLogix Inc) can aid in the diagnosis of early-stage, or subclinical, age-related macular degeneration before visual loss occurs and even before structural changes are observed, and adds to the information obtained from retina cameras and OCT imaging.